Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by quinlashon Jun 12, 2024 1:01am
54 Views
Post# 36084092

RE:RE:69+ % upside from here

RE:RE:69+ % upside from here
quinlash wrote:
quinlash wrote: I checked the price to book value and it's around .35 at the moment.  In order to be trading at book value this ratio needs to be 1.  This indicates more than 60% upside on this title.

If I were to pull up the PB Ratio on other cannabis stocks that get more media coverage we could be targeting greater upside if we are to view those ratios as plausible.

Volume has dropped off, this may be an indicator that current investors are simply not willing to sell or short the stock at these levels.

Looking forward to hearing more about the acquisition target TLRY eluded to. Expecting this new company will position the company well for US sales / entery (depending on how they go about things)

JMHO/GLTA







Minor correction.  I stated Price to Book Value when I meant to say Price to Book RATIO.

To get value from ratio just subtract ratio number from 1.  Take the result and add 1 to that and multiply by current shareprice 

Example:  with ratio of .35

1 - .35 = .65

1 + .65 = 1.65

$2.40 CDN * 1.65 = $3.96 CDN


To use a higher ratio than 1 you just add the extra ratio to step #2.  I believe CURA is at 5 or 6 (haven't looked this week)








The Price to Book RATIO I used was taken from the Quote Menu item in the stockhouse main menu.

If you disagree with the ratio number then you can take it up with Stockhouse Admin.

Others sources that can be used are Fintel, MarketBeat and even from within your own trading account assuming your broker provides basic fundamental data.

All the Best

Q



<< Previous
Bullboard Posts
Next >>